Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 39-45, 2021.
Article in Chinese | WPRIM | ID: wpr-862263

ABSTRACT

OBJECTIVE:To stu dy the improvem ent effect and mechanism of Guizhi fuling pill (GZFLP) on rats with phlegm-dampness type polycystic ovary syndrome (PCOS).METHODS:Totally fifty female SD rats with regular estrous cycle were randomly divided into blank control group (n=10) and model group (n=40). The model group received letrozole intragastrically [1 mg/(kg·d),for 21 d ] to induce phlegm-damp PCOS rat model. Forty model rats were randomly divided into model group ,metformin group [positive control ,0.135 g/(kg·d)] and GZFLP low-dose ,high-dose groups [4.49,17.96 g/(kg· d)],with 10 rats in each group. Each medicine group was given intragastric administration ,once a day ,for 30 consecutive days. Blank control and model group were given intragastric administration of equal volume normal saline.After last medication ,oral glucose tolerance test (OGTT)was used to detect the level of blood glucose in rats at 0,30,60 and 120 min. ELISA assay was used to detect the levels of follicle-stimulating hormone (FSH),luteinizing hormone (LH),estradiol(E2)and testosterone (T); body weight ,the weight of uterus ,bilateral ovaries and paragonadal fat were weighed. HE staining was used to observe morphological changes of ovarian tissue sections. RT-PCR method and Western blotting assay were used to detect mRNA and protein expression of CYP 19a1 in ovary and Glut 4 in uterine. RESULTS :Compared with blank control group ,the levels of blood glucose 30,60,120 min after intragastric administration of glucose solution as well as serum levels of LH ,E2 and T were increased significantly in model group (P<0.05);the body weight ,the weight of uterus ,bilateral ovaries and paragonadal fat were increased significantly (P<0.05);the volume of thecal cells increased significantly and showed spherical shape ;the mRNA and protein expression of CYP 19a1 in ovarian tissue and Glut 4 in uterine tissue were decreased significantly (P<0.05 or P<0.01). Compared with model group ,above indexes of administration groups were improved significantly (P<0.05 or P<0.01);the thickness of theca cell layer and the volume of theca cells in GZFLP low-dose and high-dose groups were also improved. CONCLUSIONS:GZFLP can up-regulate the expression of CYP19a1 in ovary and Glut4 in uterus ,so as to improve the abnormal glucose metabolism in phlegm-dampness type PCOS model rats ,reduce insulin resistance ,lower serum estrogen levels ,and reduce the degree of polycystic changes in ovary ,thereby playing a role in the treatment of PCOS.

2.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 2763-2767, 2020.
Article in Chinese | WPRIM | ID: wpr-866684

ABSTRACT

Objective:To investigate the application effect of dexmedetomidine combined with propofol and remifentanil in fiberoptic bronchoscopy in elderly patients with chronic obstructive pulmonary disease(COPD).Methods:From October 2018 to November 2019, 112 elderly patients with COPD who were examined by fiberoptic bronchoscopy in the Affiliated Hospital of Medical College of Ningbo University were divided into control group and observation group, with 56 cases in each group.Propofol and remifentanil were used for anesthesia induction in both two groups.Dexmedetomidine (0.5μg/kg) was injected intravenously into observation group, and later 0.5μg·kg -1·h -1 continuous infusion, the control group was given the same dose of 0.9% sodium chloride injection.The OAA/S scores, propofol dosage, remifentanil dosage, wake-up time, heart rate, oxygen saturation, mean arterial pressure, pulmonary function changes and adverse reactions were compared between the two groups. Results:At the fiberbronchoscope entered immediately and 10 min after examination, the OAA/S scores in the observation group were (1.03±0.35)points, (4.42±0.28)points, respectively, which in the control group were (1.22±0.22)points, (3.01±0.22)points, respectively, the differences between the two groups were statistically significant( t=3.439, 29.631, all P<0.05). The dosages of propofol and remifentanil in the observation group were (3.00±0.28)μg/kg and (1.65±0.29)μg/kg, respectively, which were less than those in the control group [(3.70±0.39)μg/kg, (2.42±0.45)μg/kg], the recovery time was (8.40±1.58)min, which was shorter than that in the control group [(13.31±2.02)min], the differences were statistically significant( t=10.911, 10.763, 14.327, all P<0.05). The heart rate, oxygen saturation, mean arterial pressure, pulmonary function(FEV 1, MVV) in the observation group were significantly better than those in the control group( t=9.757, 11.981, 11.486, 11.913, 40.189, all P<0.05). The incidence of adverse reactions in the observation group was 7.14%(4/56), which was lower than 19.64%(11/56) in the control group(χ 2=6.737, P<0.05). Conclusion:Dexmedetomidine(0.5μg/kg, followed by 0.5μg·kg -1·h -1 continuous infusion) and target controlled infusion of propofol and remifentanil are safe for elderly patients with COPD, and the use of anesthetic drugs is small, which can shorten the recovery time after operation, and will not have a great impact on respiratory circulation.

SELECTION OF CITATIONS
SEARCH DETAIL